Commentary

Podcast

Pegram Details the Use of Oral SERDs in ESR1+ Metastatic Breast Cancer

Fact checked by:

Dr Pegram discusses the use of oral SERDs in HR-positive metastatic breast cancer and biomarker testing practices for patients with metastatic disease.

Welcome to OncLive On Air®! I’m your host today, Ashling Wahner.

OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, supported by Stemline Therapeutics, we had the pleasure of speaking with Mark Pegram, MD, about updates in the metastatic breast cancer treatment paradigm. Dr Pegram is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology and the associate dean for Clinical Research Quality at the Stanford University School of Medicine, the associate director of Clinical Research at the Stanford Comprehensive Cancer Institute, and the medical director of the Stanford Clinical Translational Research Unit in California.

In our exclusive interview, Dr Pegram discussed the use of oral selective estrogen receptor degraders for the treatment of patients with hormone receptor–positive metastatic breast cancer, standard biomarker testing practices for patients with metastatic disease, and treatment options for patients with ESR1-mutated disease.

___

That’s all we have for today! Thank you for listening to this episode of OncLive On Air, supported by Stemline Therapeutics. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.

*OncLive On Air is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Related Content